Enzo Biochem
ENZ
$1.09
Share price
-1.80%
Change (1 day)
-54.77%
Change (1 year)
Categories
Enzo Biochem (ENZ) - Total debt
Total debt on the balance sheet as of January 2024 : $7.18 M
According to Enzo Biochem's latest financial reports the company's total debt is $7.18 M. A company’s total debt is the sum of all current and non-current debts.
Enzo Biochem - Total debt on balance sheet (from 2005 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-07-31 | $6.99 M | -24.39% |
| 2022-07-31 | $9.25 M | -59.19% |
| 2021-07-31 | $22.67 M | -30.84% |
| 2020-07-31 | $32.79 M | 617.51% |
| 2019-07-31 | $4.57 M | 1194.62% |
| 2018-07-31 | $0.35 M | -38.39% |
| 2017-07-31 | $0.57 M | -76.67% |
| 2016-07-31 | $2.45 M | -31.51% |
| 2015-07-31 | $3.58 M | -3.76% |
| 2014-07-31 | $3.72 M | -14.72% |
| 2013-07-31 | $4.36 M | 1676.02% |
| 2012-07-31 | $0.24 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $5.35 B | 74,430.01% | 🇺🇸 USA |
 LabCorp LH | $5.96 B | 83,015.17% | 🇺🇸 USA |
 RadNet RDNT | $1.49 B | 20,664.80% | 🇺🇸 USA |
 Psychemedics PMD | $2.29 M | -68.00% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.60 B | 8,369.34% | 🇺🇸 USA |
 Qiagen QGEN | $1.50 B | 20,834.97% | 🇳🇱 Netherlands |